Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative structure/property relationship analysis of Caco-2 permeability using a genetic algorithm-based partial

Fumiyoshi Yamashita1, Suchada Wanchana, Mitsuru Hashida

  • 1Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshidashimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Journal of Pharmaceutical Sciences
|September 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting plasma concentration-time profiles of orally disintegrating tablets with delayed absorption under fed conditions without water.

International journal of pharmaceutics·2026
Same author

Platform design of hybrid microphysiological system integrating in vitro and in silico models for reproducing insulin-regulated glucose metabolism.

Scientific reports·2026
Same author

Enhancing Antigen Recognition of Living Cells by Site-Specific VHH Antibody Conjugation.

Chembiochem : a European journal of chemical biology·2025
Same author

Harnessing large language models for structured extraction of cytochrome P450-substance interactions from biomedical texts.

International journal of pharmaceutics·2025
Same author

Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir.

In vivo (Athens, Greece)·2025
Same author

Enhancing Intracellular Uptake of Ivermectin through Liposomal Encapsulation.

AAPS PharmSciTech·2025

This study developed a quantitative structure-property relationship (QSPR) model to predict Caco-2 permeability using a genetic algorithm-partial least squares (GA-PLS) method, achieving high prediction accuracy for drug absorption.

Area of Science:

  • Pharmacokinetics
  • Computational Chemistry
  • Drug Discovery

Background:

  • Caco-2 cell monolayers are a standard in vitro model for predicting intestinal drug absorption.
  • Accurate prediction of Caco-2 permeability is crucial for early-stage drug development.
  • Existing QSPR models may require optimization for improved predictive power.

Purpose of the Study:

  • To develop a novel Quantitative Structure-Property Relationship (QSPR) model for Caco-2 permeability.
  • To utilize a genetic algorithm-based partial least squares (GA-PLS) method for QSPR model development.
  • To enhance the prediction accuracy of intestinal drug absorption using molecular descriptors.

Main Methods:

  • Collected Caco-2 permeability data for 73 compounds from existing literature.

Related Experiment Videos

  • Calculated Molconn-Z descriptors for each compound.
  • Employed GA-PLS to identify an optimal subset of molecular descriptors.
  • Utilized a fitness function balancing training fit and testing predictability.
  • Performed leave-some-out cross-validation for model evaluation.
  • Main Results:

    • Developed a PLS model incorporating 24 molecular descriptors.
    • Achieved a correlation coefficient (r) of 0.886 for the entire dataset.
    • Obtained a predictive correlation coefficient (r(pred)) of 0.825 via cross-validation.
    • Demonstrated the effectiveness of GA-PLS in selecting relevant descriptors.

    Conclusions:

    • The GA-PLS method is a robust approach for QSPR modeling of Caco-2 permeability.
    • The developed model shows significant potential for predicting intestinal drug absorption.
    • This QSPR model can aid in the efficient screening of drug candidates.